Entrada Therapeutics, Inc.
TRDA
$6.37
$0.111.76%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.37% | -29.60% | -27.26% | -24.64% | 16.83% |
| Total Receivables | -49.67% | -52.97% | -15.96% | -62.75% | -94.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.72% | -49.74% | -32.53% | 9.69% | 95.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.81% | -30.40% | -27.31% | -24.59% | -2.65% |
|
|
|||||
| Total Current Assets | -33.81% | -30.40% | -27.31% | -24.59% | -2.65% |
| Net Property, Plant & Equipment | -17.49% | -17.41% | -16.59% | -13.95% | -12.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -19.26% | -20.60% | -12.41% | -11.67% | -37.59% |
| Total Assets | -31.03% | -28.30% | -25.55% | -22.88% | -4.77% |
|
|
|||||
| Total Accounts Payable | 33.91% | -46.25% | 145.05% | 13.58% | -13.42% |
| Total Accrued Expenses | 64.26% | 34.17% | 19.17% | 12.11% | -16.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.24% | -45.26% | -43.78% | -36.24% | -21.58% |
| Total Finance Division Other Current Liabilities | -67.70% | -90.13% | -96.56% | -98.23% | -98.04% |
| Total Other Current Liabilities | -67.70% | -90.13% | -96.56% | -98.23% | -98.04% |
| Total Current Liabilities | 4.15% | -38.07% | -65.98% | -76.92% | -89.40% |
|
|
|||||
| Total Current Liabilities | 4.15% | -38.07% | -65.98% | -76.92% | -89.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.94% | -9.40% | -10.31% | -11.80% | -13.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -98.58% | -98.13% | -96.80% |
| Total Liabilities | -6.58% | -27.04% | -45.38% | -54.43% | -71.34% |
|
|
|||||
| Common Stock & APIC | 3.53% | 3.68% | 4.00% | 4.06% | 27.76% |
| Retained Earnings | -113.24% | -111.14% | -79.29% | -62.99% | 14.45% |
| Treasury Stock & Other | -43.71% | 1,616.28% | -36.11% | 221.58% | 277.64% |
| Total Common Equity | -35.09% | -28.59% | -19.35% | -11.73% | 54.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.09% | -28.59% | -19.35% | -11.73% | 54.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.09% | -28.59% | -19.35% | -11.73% | 54.90% |
|
|
|||||